Aurinia Pharmaceuticals (AUPH) Prepaid Assets (2016 - 2026)
Aurinia Pharmaceuticals (AUPH) reported Prepaid Assets of $1.8 million for Q1 2026, up 124.97% on a YoY basis from $781000.0 in Q1 2025, and up 62.69% quarter-over-quarter from $1.1 million in Q4 2025.
Aurinia Pharmaceuticals (AUPH) Prepaid Assets (2016 - 2026) Analysis & Trends
Aurinia Pharmaceuticals has reported Prepaid Assets for 11 years, with the latest figure at $1.8 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 124.97% year-over-year to $1.8 million; the trailing twelve-month figure through Mar 2026 stood at $1.8 million (up 124.97% YoY), and the FY2025 full-year result was $1.1 million, down 90.37% from the prior year.
- Prepaid Assets for Q1 2026 stood at $1.8 million, up from $1.1 million in the prior quarter.
- The five-year high for Prepaid Assets was $17.4 million in Q2 2022, with the low at $665000.0 in Q2 2025.
- Historically, Prepaid Assets has averaged $7.5 million across 5 years, with a median of $7.6 million in 2024.
- Annual changes were most pronounced in 2023 — Prepaid Assets jumped 611.09% — and 2025, when it slumped 90.47%.
- Aurinia Pharmaceuticals' Prepaid Assets stood at $1.3 million in 2022, then jumped by 611.09% to $9.5 million in 2023, then gained by 18.27% to $11.2 million in 2024, then tumbled by 90.37% to $1.1 million in 2025, then surged by 62.69% to $1.8 million in 2026.
- The last three Prepaid Assets figures came in at $1.8 million (Q1 2026), $1.1 million (Q4 2025), and $11.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Aurinia Pharmaceuticals | 2.18 Bn | 1.80 Bn | 71.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.76 Mn |
| Dec 31, 2025 | 1.08 Mn |
| Sep 30, 2025 | 11.11 Mn |
| Jun 30, 2025 | 665,000.00 |
| Mar 31, 2025 | 781,000.00 |
| Dec 31, 2024 | 11.22 Mn |
| Sep 30, 2024 | 13.82 Mn |
| Jun 30, 2024 | 6.98 Mn |
| Mar 31, 2024 | 7.65 Mn |
| Dec 31, 2023 | 9.49 Mn |
| Sep 30, 2023 | 16.16 Mn |
| Jun 30, 2023 | 11.33 Mn |
| Mar 31, 2023 | 1.23 Mn |
| Dec 31, 2022 | 1.33 Mn |
| Sep 30, 2022 | 3.81 Mn |
| Jun 30, 2022 | 17.42 Mn |
| Mar 31, 2022 | 12.20 Mn |
| Dec 31, 2021 | 11.71 Mn |
| Sep 30, 2021 | 13.71 Mn |
| Jun 30, 2021 | 9.16 Mn |